Central Alerting System: Novel Coronavirus – Anti-Inflammatory Medications

Central Alerting System: Novel Coronavirus – Anti-Inflammatory Medications

March 18, 2020

Alert Reference: CEM/CMO/2020/10

NHS England has today issued guidance on the use of non-steroidal anti-inflammatory medications (NSAIDs) in relation to Covid-19.

“There appears to be no evidence that NSAIDs increase the chance of acquiring Covid-19. In view of the current lack of clarity the Committee of Human Medicines (an advisory body of MHRA) and NICE have been asked to review the evidence. It is therefore suggested that, in the interim, for patients, who have confirmed Covid-19 or believe they have Covid-19, that they use paracetamol in preference to NSAIDs.

Those currently on NSAIDs for other medical reasons (e.g. arthritis) should not stop them.”

View the alert


Posted in: , , ,

More Latest News >

PRSB to update pharmacy IT standards

The Professional Record Standards Body (PRSB) previously established Pharmacy information flows IT standards. PRSB are now working with RPS, PSNC,  Community...

Christmas Bank Holiday Opening

In today’s Primary Care Bulletin email, NHS England and NHS Improvement (NHSE&I) confirmed that there is currently no intention to...